$16.97
0.71% today
NYSE, Dec 24, 07:10 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Stock price

$16.85
-1.77 9.51% 1M
-2.75 14.03% 6M
-50.37 74.93% YTD
-49.81 74.72% 1Y
-187.35 91.75% 3Y
-90.58 84.32% 5Y
-16.59 49.61% 10Y
NYSE, Closing price Mon, Dec 23 2024
-0.07 0.41%
ISIN
US58470H1014
Symbol
MED

Key metrics

Market capitalization $184.30m
Enterprise Value $31.97m
P/E (TTM) P/E ratio 25.21
EV/FCF (TTM) EV/FCF 0.95
EV/Sales (TTM) EV/Sales 0.05
P/S ratio (TTM) P/S ratio 0.27
P/B ratio (TTM) P/B ratio 0.89
Dividend yield 38.93%
Last dividend (FY22) $6.56
Revenue growth (TTM) Revenue growth -44.64%
Revenue (TTM) Revenue $674.48m
EBIT (operating result TTM) EBIT $10.85m
Free Cash Flow (TTM) Free Cash Flow $33.83m
Cash position $169.96m
EPS (TTM) EPS $0.67
P/E forward negative
P/S forward 0.31
EV/Sales forward 0.05
Short interest 22.52%
Show more

Is Medifast Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Medifast Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Medifast Inc forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Medifast Inc forecast:

Hold
100%

Financial data from Medifast Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
674 674
45% 45%
100%
- Direct Costs 177 177
48% 48%
26%
498 498
43% 43%
74%
- Selling and Administrative Expenses 467 467
32% 32%
69%
- Research and Development Expense 4.40 4.40
4% 4%
1%
26 26
86% 86%
4%
- Depreciation and Amortization 15 15
14% 14%
2%
EBIT (Operating Income) EBIT 11 11
94% 94%
2%
Net Profit 7.33 7.33
94% 94%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Medifast Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medifast Inc Stock News

Neutral
Business Wire
19 days ago
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medicat...
Positive
Seeking Alpha
about 2 months ago
Medifast reported better-than-expected quarterly EPS and is investing in new marketing strategies, AI technologies, and supply chain optimization to drive future growth. Despite a decline in the number of coaches and productivity, MED trades close to its book value and continues to generate free cash flow. The company's stock repurchase plan and significant cash reserves indicate confidence in ...
Neutral
Seeking Alpha
about 2 months ago
Medifast, Inc. (NYSE:MED ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Officer Jim Maloney - Chief Financial Officer Conference Call Participants Jim Salera - Stephens Inc. Linda Bolton-Weiser - D.A. Davidson Operator Greetings, and welcome to the Medifast Third Quarter...
More Medifast Inc News

Company Profile

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD

Head office United States
CEO Daniel Chard
Employees 634
Founded 1981
Website www.medifastinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today